Shopping Cart
- Remove All
- Your shopping cart is currently empty
VEGF165B Protein, Human, Recombinant is expressed in Baculovirus-Insect Cells. The accession number is P15692-8.
Pack Size | Price | Availability | Quantity |
---|
Biological Activity | Activity testing is in progress. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first. |
Description | VEGF165B Protein, Human, Recombinant is expressed in Baculovirus-Insect Cells. The accession number is P15692-8. |
Protein Purity | > 95% as determined by SDS-PAGE. |
Molecular Weight | 19.1 kDa (predicted) |
Research Background | Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and often exists as a disulfide-linked homodimer. VEGF-A protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, inhibiting apoptosis and tumor growth. VEGF-A protein is also a vasodilator that increases microvascular permeability, thus it was originally referred to as vascular permeability factor.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.